# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-612675
Filing Date
2016-06-03
Accepted
2016-06-03 16:27:41
Documents
15
Period of Report
2016-07-14
Effectiveness Date
2016-06-03

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d175958ddef14a.htm | DEF 14A | 806006
2 | GRAPHIC | g175958dotdot.jpg | GRAPHIC | 349
3 | GRAPHIC | g175958stp003.jpg | GRAPHIC | 114395
4 | GRAPHIC | g175958stp004.jpg | GRAPHIC | 121803
5 | GRAPHIC | g175958stp005.jpg | GRAPHIC | 153789
6 | GRAPHIC | g175958stp006a.jpg | GRAPHIC | 9962
7 | GRAPHIC | g175958stp006b.jpg | GRAPHIC | 7972
8 | GRAPHIC | g175958stp085.jpg | GRAPHIC | 57316
9 | GRAPHIC | g175958stp086.jpg | GRAPHIC | 236841
10 | GRAPHIC | g175958stp087.jpg | GRAPHIC | 140323
11 | GRAPHIC | g175958stp088.jpg | GRAPHIC | 119172
12 | GRAPHIC | g175958stp089.jpg | GRAPHIC | 137757
13 | GRAPHIC | g175958txpg004a.jpg | GRAPHIC | 1716
14 | GRAPHIC | g175958txpg004b.jpg | GRAPHIC | 1043
15 | GRAPHIC | g175958txpg004c.jpg | GRAPHIC | 1266
| Complete submission text file | 0001193125-16-612675.txt |  | 2326349

Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 161696022
SIC: 2834 Pharmaceutical Preparations